There's been a new addition to the market-trouncing Retail Roundup10 Portfolio.

Click here to see what stock I'm adding as Wall Street squirms. 

Thanks to everyone who joined us for the June 11 Hot Corner Insider Weekly Strategy Session.

When my friend and client—who manages a three-commas portfolio—calls me with a trade idea, I listen.

Sure, he’s human like the rest of us. Prone to bias, emotion, and the occasional bad read. But over the years, he’s earned my respect. He’s sharp, curious, and often brings fresh perspective to the table. So when his name pops up on my phone, I answer.

This week, he rang me up to talk about a stock that’s down 95% from its highs.

I’ll be honest—where I come from, we call that dumpster diving.

But as he laid out his case, I started to lean in.

He noted signs of a likely turn in the broader sector. He pointed out a major price gap from ten months ago that, if filled, could offer serious upside. And he reminded me that the stock in question is a “story stock”—the kind momentum traders love to chase if the price action gives them the green light.

While we talked, I pulled up the options chain and started scanning out in time—way out.

I found a June 2026 call with a roughly 1-in-4 shot of landing in the money. But if we’re right and that gap fills? That option could return 30x.

Today's trade is in a stock that has been seemingly left for dead. Which is ironic, considering this company is engaged in keeping people alive.

This biotech company is an astounding 95% off it's 2021 highs.

But here's the thing... this stock just crossed above its 50-day moving average and appears to be holding there. And with a new leg higher in the stock market likely to lift a lot of boats, there is opportunity here.

From the desk of Steve Strazza @Sstrazza

Welcome to The 2 to 100 Club.

In this scan, we look to identify the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

Some of the best performers in recent decades – stocks like Priceline, Amazon, Netflix, Salesforce, and myriad others – would have been on this list at some point during their journey to becoming the market behemoths they are today.

When you look at the stocks in our table, you'll notice we're only focused on Technology and Growth industry groups such as Software, Semiconductors, Online...

In today’s Daily Digest, we’ll review the following:

1. No new positions today.
2. Adjustment to KRE position.
3. No exits since the last report.
4. Current status of open campaigns.
5. Volatility Snapshot.

Let’s dig in!

Starbucks shares are racing toward $100 on "market chatter" of a possible China exit.

Here's why it matters and what it means for the stock.

J.M. Smucker $SJM just reminded investors that not even iconic consumer brands are immune to execution risk.

The $10B packaged food giant reported mixed results on Tuesday and suffered the worst earnings reaction in company history.

And it wasn’t just the headline numbers.

The company revised its long-term growth expectations lower for its recently acquired Sweet Baked Snacks portfolio.

They also lowered forward EPS guidance below consensus expectations.

These aren’t isolated issues. 

They reflect broader challenges of a flawed growth strategy.

For decades, this was a defensive compounder, anchored by brands like Jif, Folgers, Uncrustables, and Smucker’s jam. 

But its recent shift into new categories, primarily through the Hostess acquisition, hasn’t gone as smoothly as hoped.

Margins are under pressure, and inventory costs are increasing.

The market’s verdict? It’s an apparent loss of confidence.

So what else did we learn from this earnings report? Let’s dive into the details.

*Click the image to enlarge it

J.M....

Stitch Fix keeps refusing to die. The all-but-forgotten clothing box membership service is seeing shares jump after losing less and selling more than analysts expected in Q3. What should you do with shares near 2025 highs and up more than 100% since April 7th? 

Get my full report card on SFIX's quarter and how I'm playing the stock.  

I break down the quarter and give the company its full grade for members in the LINK

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 Vitesse Energy $VTS – CEO Robert Gerrity filed a Form 4, revealing a purchase of 10,000 shares, equivalent to $232,900.

It’s not massive, but it’s a clean open-market buy in a small-cap energy name. I’m keeping a close eye on the whole energy complex as Crude Oil looks wound up for a classic bear trap. 

📌 Chemours Company $CC – Millennium Management just showed its hand, revealing a fresh 13G filing with a 6.1% stake.

Here’s The Hot Corner, with data from June 10, 2025:

Click the table to enlarge it.

📌 ICF...

You may have noticed a theme in these notes.

That is, we sound like huge optimists.

But that's for a simple reason that being an optimist has paid off big in 2025 - even with all the volatility we've seen. In fact, while the S&P 500 is only up +1.60% this year, the average buyer is up +5.60% when you take into account dollar cost averaging.

More stocks keep breaking out and investors are being rewarded for buying into it.

And another major breakout just happened.

Industrials $XLI, one of the world's most important sectors, just made all time highs.

On Monday, we talked about the generational breakout in global stocks.

Yesterday, we touched on how the prospects for the riskiest companies in the world are looking great.

And today, we just have to touch on how the most important sector in the world is making all time highs.

Investors are being rewarded for their optimism, even throughout the ups and downs of this year. And with the way these breakouts are manifesting, we're continuing to bet that remains the case.

Today's number is... 83

We’ve now seen 83 consecutive trading days where the 3-month rolling fund flow for the Russell 2000 (IWM) has been negative — a stretch small caps haven’t experienced since mid-2019.

Here’s the chart:

Let's break down what the chart shows:

• The green and red candlesticks in the top panel show the price of the Russell 2000.
• The green and red line in the bottom panel shows the rolling 3-month net fund flows for the Russell 2000.

The Takeaway: Nobody wants small caps right now.

And that’s exactly why I’m watching them.

Negative flows for this long isn’t just rare — it’s a clear sign of bearish sentiment.

Historically, when flows dry up like this, it reflects a market that’s been abandoned… and often sets the stage for a reversal.

But it’s not just fund flows.

Short interest in small caps is near 18-month highs.

Traders are leaning heavily against the space — and that kind of crowding rarely ends quietly.

It has also been 899 days since IWM last reached an all-time high.

Sign up for my free note here.

The biggest development this week is unfolding in the market’s most risk-on corners.

When we look down the cap scale, small-cap stocks are breaking out—reclaiming a key level of resistance at the index level.

The Russell 2000 $IWM didn’t just punch through a horizontal brick wall—it also broke above a downward trendline that’s been in place since the highs from last year.

Most importantly, it’s now trading above the anchored VWAP from its all-time high.

That last point is crucial—it means the average buyer since the Russell’s peak is finally in the green.

Buyers are back in control, marking a major development that reinforces the bullish thesis for equities.

...

One of the top-performing areas of the speculative growth theme has been the “new-school” nuclear trade. 

OKLO already tagged one target, SMR is on its way, and NNE is coiled and wants next. 

Click the link to read our nuclear energy deep dive.

These have been some of the top stocks off the April lows, and now the old-school names like Cameco $CCJ are powering higher too.

What I’m saying is the entire nuclear space is red-hot, and I want more of it.

Here’s the VanEck Uranium & Nuclear ETF $NLR breaking out to its highest level since 2008.

After a 50% move in two months’ time, one might think this trend is extended, but it’s not. 

This is a fresh breakout over longer timeframes, and price should keep climbing...

Back in early April, I made a bet that silver would play catch-up to the vastly outperforming gold complex utilizing an options trader's version of a pairs trade. You can read about it here.

Both instruments had a bit of a wild ride following the "Liberation Day" Luau, especially SLV. But thanks to the somewhat offsetting risks of the short-biased GLD trade, we road out the volatility admirably.

Today, following SLV's recent run and dramatic outperformance against GLD, I think now is the time to take our profits.

There weren’t any S&P 500 earnings reactions yesterday…

But one recent move continues to stand out.

There’s a quiet resurgence happening in one of the market’s most forgotten corners: Genomics.

The industry has been left for dead after peaking during the 2020 to 2021 boom and suffering an 85% collapse.

But buried under the wreckage are a few real businesses making real progress.

One of them is Adaptive Biotechnologies $ADPT, a $1.6B biotech company on a mission to decode the immune system.

Their goal is simple but revolutionary: make the immune response a measurable, actionable source of insight for diagnosing and treating disease.

They’re already delivering on that promise through clonoSEQ, their flagship test for monitoring minimal residual disease in blood cancers. 

This product is seeing strong clinical uptake and broader support from payers and regulators.

What’s even more exciting is who they’re building with.

They’ve partnered with Microsoft $MSFT to apply machine learning at scale to immune...

In today’s Daily Digest, we’ll review the following:

1. New position in XLB.
2. No adjustments are needed today.
3. No exits since the last report.
4. Current status of open campaigns.
5. Volatility Snapshot.

Let’s dig in!

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 Plug Power $PLUG – The CFO Paul Middleton stepped in with another purchase of his company’s stock. 

This is the second purchase he’s made this year, and this comes on the heels of a massive 25% bounce off a key long-term support level dating back to 2017. 

📌 PBF Energy Inc $PBF – Control Empresarial de Capitales S.A. revealed an acquisition of 48,500 shares, equivalent to $872,340.

Here’s The Hot Corner, with data from June 9, 2025:

Click the table to enlarge it.

📌 Appfolio Inc $APPF – Director Robert Donald Casey III stepped in with an eye-catching purchase for $870,000 just as the stock flirts with...